Cargando…

Dynamic Dossier in the Cloud: A Sociotechnical Architecture for a Real-Time and Metrics-Based Data Tracking System with Gene and Cell Therapies as a Case Study

BACKGROUND: Data sharing among stakeholders in the development, access, and use of drug therapies is critical but the current system and process are inefficient. METHODS: We take a Systems Engineering approach with a realistic use case to propose a scalable design for multi-stakeholder data sharing....

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Kevin, Larholt, Kay, Hirsch, Gigi, Beninger, Paul, Fritsche, David, Shoda, Diane, Ferguson, John, Bourgeois, Florence T., Palmer, Donna, Katz, Karen, Courtney, Matt W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864828/
https://www.ncbi.nlm.nih.gov/pubmed/33118143
http://dx.doi.org/10.1007/s43441-020-00227-y
_version_ 1783647728247504896
author Nam, Kevin
Larholt, Kay
Hirsch, Gigi
Beninger, Paul
Fritsche, David
Shoda, Diane
Ferguson, John
Bourgeois, Florence T.
Palmer, Donna
Katz, Karen
Courtney, Matt W.
author_facet Nam, Kevin
Larholt, Kay
Hirsch, Gigi
Beninger, Paul
Fritsche, David
Shoda, Diane
Ferguson, John
Bourgeois, Florence T.
Palmer, Donna
Katz, Karen
Courtney, Matt W.
author_sort Nam, Kevin
collection PubMed
description BACKGROUND: Data sharing among stakeholders in the development, access, and use of drug therapies is critical but the current system and process are inefficient. METHODS: We take a Systems Engineering approach with a realistic use case to propose a scalable design for multi-stakeholder data sharing. RESULTS: We make three major contributions to the drug development and healthcare communities: first, a methodology for developing a multi-stakeholder data sharing system, with its focus on high-level requirements that influence the design of the system architecture and technology choice; second, the development of a realistic use case for long-term patient and therapy data tracking and sharing in the use of potentially curative and durable gene and cell therapies. Further, a bridge for the ‘awareness gap’ was found between the payer (Payer is organization which takes care of financial and operational aspects (which include insurance plans, provider network) of providing health care to US citizens. Or refer to health care insurers.) and the regulator communities by illustrating the common data tracking needs, which highlights the need for coordinated data activities; and third, a proposed system architecture for scalable, multi-stakeholder data sharing. Next steps are briefly discussed. CONCLUSION: We present a system design for multiple stakeholders such as the payer, the regulator, the developer (drug manufacturer), and the healthcare provider to share data for their decision-making. The stakeholder community would benefit from collaboratively moving the system development proposal forward for efficient and cost-effective data sharing.
format Online
Article
Text
id pubmed-7864828
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-78648282021-02-16 Dynamic Dossier in the Cloud: A Sociotechnical Architecture for a Real-Time and Metrics-Based Data Tracking System with Gene and Cell Therapies as a Case Study Nam, Kevin Larholt, Kay Hirsch, Gigi Beninger, Paul Fritsche, David Shoda, Diane Ferguson, John Bourgeois, Florence T. Palmer, Donna Katz, Karen Courtney, Matt W. Ther Innov Regul Sci Original Research BACKGROUND: Data sharing among stakeholders in the development, access, and use of drug therapies is critical but the current system and process are inefficient. METHODS: We take a Systems Engineering approach with a realistic use case to propose a scalable design for multi-stakeholder data sharing. RESULTS: We make three major contributions to the drug development and healthcare communities: first, a methodology for developing a multi-stakeholder data sharing system, with its focus on high-level requirements that influence the design of the system architecture and technology choice; second, the development of a realistic use case for long-term patient and therapy data tracking and sharing in the use of potentially curative and durable gene and cell therapies. Further, a bridge for the ‘awareness gap’ was found between the payer (Payer is organization which takes care of financial and operational aspects (which include insurance plans, provider network) of providing health care to US citizens. Or refer to health care insurers.) and the regulator communities by illustrating the common data tracking needs, which highlights the need for coordinated data activities; and third, a proposed system architecture for scalable, multi-stakeholder data sharing. Next steps are briefly discussed. CONCLUSION: We present a system design for multiple stakeholders such as the payer, the regulator, the developer (drug manufacturer), and the healthcare provider to share data for their decision-making. The stakeholder community would benefit from collaboratively moving the system development proposal forward for efficient and cost-effective data sharing. Springer International Publishing 2020-10-28 2021 /pmc/articles/PMC7864828/ /pubmed/33118143 http://dx.doi.org/10.1007/s43441-020-00227-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Research
Nam, Kevin
Larholt, Kay
Hirsch, Gigi
Beninger, Paul
Fritsche, David
Shoda, Diane
Ferguson, John
Bourgeois, Florence T.
Palmer, Donna
Katz, Karen
Courtney, Matt W.
Dynamic Dossier in the Cloud: A Sociotechnical Architecture for a Real-Time and Metrics-Based Data Tracking System with Gene and Cell Therapies as a Case Study
title Dynamic Dossier in the Cloud: A Sociotechnical Architecture for a Real-Time and Metrics-Based Data Tracking System with Gene and Cell Therapies as a Case Study
title_full Dynamic Dossier in the Cloud: A Sociotechnical Architecture for a Real-Time and Metrics-Based Data Tracking System with Gene and Cell Therapies as a Case Study
title_fullStr Dynamic Dossier in the Cloud: A Sociotechnical Architecture for a Real-Time and Metrics-Based Data Tracking System with Gene and Cell Therapies as a Case Study
title_full_unstemmed Dynamic Dossier in the Cloud: A Sociotechnical Architecture for a Real-Time and Metrics-Based Data Tracking System with Gene and Cell Therapies as a Case Study
title_short Dynamic Dossier in the Cloud: A Sociotechnical Architecture for a Real-Time and Metrics-Based Data Tracking System with Gene and Cell Therapies as a Case Study
title_sort dynamic dossier in the cloud: a sociotechnical architecture for a real-time and metrics-based data tracking system with gene and cell therapies as a case study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864828/
https://www.ncbi.nlm.nih.gov/pubmed/33118143
http://dx.doi.org/10.1007/s43441-020-00227-y
work_keys_str_mv AT namkevin dynamicdossierinthecloudasociotechnicalarchitectureforarealtimeandmetricsbaseddatatrackingsystemwithgeneandcelltherapiesasacasestudy
AT larholtkay dynamicdossierinthecloudasociotechnicalarchitectureforarealtimeandmetricsbaseddatatrackingsystemwithgeneandcelltherapiesasacasestudy
AT hirschgigi dynamicdossierinthecloudasociotechnicalarchitectureforarealtimeandmetricsbaseddatatrackingsystemwithgeneandcelltherapiesasacasestudy
AT beningerpaul dynamicdossierinthecloudasociotechnicalarchitectureforarealtimeandmetricsbaseddatatrackingsystemwithgeneandcelltherapiesasacasestudy
AT fritschedavid dynamicdossierinthecloudasociotechnicalarchitectureforarealtimeandmetricsbaseddatatrackingsystemwithgeneandcelltherapiesasacasestudy
AT shodadiane dynamicdossierinthecloudasociotechnicalarchitectureforarealtimeandmetricsbaseddatatrackingsystemwithgeneandcelltherapiesasacasestudy
AT fergusonjohn dynamicdossierinthecloudasociotechnicalarchitectureforarealtimeandmetricsbaseddatatrackingsystemwithgeneandcelltherapiesasacasestudy
AT bourgeoisflorencet dynamicdossierinthecloudasociotechnicalarchitectureforarealtimeandmetricsbaseddatatrackingsystemwithgeneandcelltherapiesasacasestudy
AT palmerdonna dynamicdossierinthecloudasociotechnicalarchitectureforarealtimeandmetricsbaseddatatrackingsystemwithgeneandcelltherapiesasacasestudy
AT katzkaren dynamicdossierinthecloudasociotechnicalarchitectureforarealtimeandmetricsbaseddatatrackingsystemwithgeneandcelltherapiesasacasestudy
AT courtneymattw dynamicdossierinthecloudasociotechnicalarchitectureforarealtimeandmetricsbaseddatatrackingsystemwithgeneandcelltherapiesasacasestudy